Literature DB >> 21030985

First oral warfarin alternative approved in the US.

Bethan Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030985     DOI: 10.1038/nrd3322

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

Review 1.  A new oral anticoagulant: the 50-year challenge.

Authors:  David Gustafsson; Ruth Bylund; Thomas Antonsson; Ingemar Nilsson; Jan-Erik Nyström; Ulf Eriksson; Ulf Bredberg; Ann-Catrine Teger-Nilsson
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

2.  Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Authors:  Lars Wallentin; Salim Yusuf; Michael D Ezekowitz; Marco Alings; Marcus Flather; Maria Grazia Franzosi; Prem Pais; Antonio Dans; John Eikelboom; Jonas Oldgren; Janice Pogue; Paul A Reilly; Sean Yang; Stuart J Connolly
Journal:  Lancet       Date:  2010-09-18       Impact factor: 79.321

  2 in total
  5 in total

1.  Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.

Authors:  Yongmei Xu; Sayaka Masuko; Majde Takieddin; Haoming Xu; Renpeng Liu; Juliana Jing; Shaker A Mousa; Robert J Linhardt; Jian Liu
Journal:  Science       Date:  2011-10-28       Impact factor: 47.728

2.  National trends in oral anticoagulant use in the United States, 2007 to 2011.

Authors:  Kate Kirley; Dima M Qato; Rachel Kornfield; Randall S Stafford; G Caleb Alexander
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-09-04

3.  Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi.

Authors:  Austin A Robinson; Cory R Trankle; Grayson Eubanks; Christopher Schumann; Paul Thompson; Ryan L Wallace; Shouri Gottiparthi; Benjamin Ruth; Christopher M Kramer; Michael Salerno; Kenneth C Bilchick; Cody Deen; Michael C Kontos; John Dent
Journal:  JAMA Cardiol       Date:  2020-06-01       Impact factor: 14.676

4.  Coagulopathy and Extremely Elevated PT/INR after Dabigatran Etexilate Use in a Patient with End-Stage Renal Disease.

Authors:  Joonseok Kim; Mrinal Yadava; In Chul An; Abrar Sayeed; Heather S Laird-Fick; Venu Gourineni; George S Abela
Journal:  Case Rep Med       Date:  2013-09-18

5.  Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010-2015.

Authors:  Thamir M Alshammari; Sondus I Ata; Mansour Adam Mahmoud; Tariq M Alhawassi; Hisham S Aljadhey
Journal:  Ther Clin Risk Manag       Date:  2018-05-01       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.